Schools in the Searcy County School District closed Friday after two confirmed cases of norovirus, officials said.

A new nanoparticle vaccine could one day give patients immunity to the flu with fewer trips to the doctor and without ...

Flu season typically begins in the fall and peaks during the winter months from December through February. The CDC recommends most people get their flu shot in September or October for optimal ...

Share on Pinterest The FDA approved a new mRNA flu vaccine for older adults ahead of the upcoming 2026–2027 flu season. fotostorm/E+/Getty Images The Food and Drug Administration (FDA) has approved a ...

The United States is finally getting a new type of flu shot. On August 5, the Food and Drug Administration (FDA) approved the mFlusiva vaccine for adults ages 50 and up. Made by biotechnology company ...

The Food and Drug Administration last week approved a first-of-its-kind flu vaccine that uses mRNA technology — the same technology used to create COVID-19 shots. The vaccine, called mFLUSIVA, is ...

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...

Add Yahoo as a preferred source to see more of our stories on Google. President Donald Trump, flanked by Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci, speaks ...

Researchers found the shot to be about 27% more effective than the standard flu shot JOSEPH PREZIOSO/AFP via Getty Moderna’s mRNA flu vaccine, mFlusiva, is approved for adults 50 and older, and is 27% ...

The U.S. Food and Drug Administration has approved a new flu vaccine, Moderna's mFlusiva, marking the public release of the first non-COVID-related mRNA vaccine in the U.S. Moderna's vaccine was ...

The U.S. Food and Drug Administration has approved Moderna's mRNA-based flu vaccine for people aged 50 and older — a complete reversal from an earlier refusal to review the shot. The approval clears ...

The Food and Drug Administration on Wednesday approved the U.S.’ first flu shot that uses mRNA technology: mFlusiva, from drugmaker Moderna. The FDA granted approval for two age groups, adults 50 to ...